Analysis of the Usefulness of the WORSEN Score for Predicting the Deterioration of Acute Ischemic Stroke
Early neurological worsening is associated with increased mortality and long-term functional disability. We developed the WORSEN score for predicting whether patients with stroke will deteriorate during the week after stroke onset and investigated its usefulness. We retrospectively investigated the...
Gespeichert in:
Veröffentlicht in: | Journal of stroke and cerebrovascular diseases 2017-12, Vol.26 (12), p.2834-2839 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2839 |
---|---|
container_issue | 12 |
container_start_page | 2834 |
container_title | Journal of stroke and cerebrovascular diseases |
container_volume | 26 |
creator | Miyamoto, Nobukazu Tanaka, Ryota Ueno, Yuji Watanabe, Masao Kurita, Naohide Hira, Kenichiro Shimada, Yoshiaki Kuroki, Takuma Yamashiro, Kazuo Urabe, Takao Hattori, Nobutaka |
description | Early neurological worsening is associated with increased mortality and long-term functional disability. We developed the WORSEN score for predicting whether patients with stroke will deteriorate during the week after stroke onset and investigated its usefulness.
We retrospectively investigated the cases of 478 patients who were admitted to Juntendo University Hospital between April 2007 and March 2009. Neurological deterioration was defined as a worsening of 4 points or higher on the National Institute of Health Stroke Scale score within 1 week of admission. Based on a previous study, we developed the WORSEN score, which was derived from the following factors: wrong (poor) blood sugar control (W), old myocardial infarction (O), radiological findings (R), infarct size (S), elevated low-density lipoprotein cholesterol (E), and neurological findings (N). Next, we investigated the utility of this scoring system in 456 other patients who were admitted to Juntendo University Hospital and Juntendo Urayasu Hospital between October 2013 and December 2014.
First, we checked the utility of the WORSEN score for detecting worsening in cases of stroke. In the first patient group, deterioration was noted in 32.5% of the patients with scores higher than 3 points (sensitivity: .704 and specificity: .744). For checking reproductivity on using the second group, deterioration was detected in 36.1% of the patients with WORSEN scores higher than 3 points (sensitivity: .740 and specificity: .835).
Careful attention should be paid to patients with acute stroke with high WORSEN scores. The WORSEN score might become a valuable tool for detecting the neurological deterioration of ischemic stroke. |
doi_str_mv | 10.1016/j.jstrokecerebrovasdis.2017.07.005 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1927304634</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1052305717303622</els_id><sourcerecordid>1927304634</sourcerecordid><originalsourceid>FETCH-LOGICAL-c470t-afb2563f0f422e54e3064be68a6e0ff320dd6046e439b455f5183e6cc558e8943</originalsourceid><addsrcrecordid>eNqVkFtP3DAQha2qFdAtf6HKY1Up2_EtyT5uubRIq4K6IB6txBmzXrIxeBwk_j3ZXcpTX5BG8mh85hz7Y-w7hykHXvxYT9eUYrhHixGbGJ5qaj1NBfByCmOB_sCOuJYirzTnH8cetMgl6PKQfSZaA3CuK33ADkVVVkqUsyO2mvd190yesuCytMLshtANXY_0Nrm9_Ls8-5MtbYiYuRCzq4itt8n3d7v7U0wYfYh18qHfLs3tkDC7ILvCjbfZcvfmL-yTqzvC49dzwm7Oz65PfueLy18XJ_NFblUJKa9dI3QhHTglBGqFEgrVYFHVBYJzUkDbFqAKVHLWKK2d5pXEwlqtK6xmSk7Yt73vQwyPA1IyG08Wu67uMQxk-EyUcjSQW-nPvdTGQBTRmYfoN3V8NhzMlrhZm_8RN1viBsYCPZp8fc0bmg22bxb_EI-CxV6A46-fPEZD1mNvR4YRbTJt8O_JewG2H6Co</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1927304634</pqid></control><display><type>article</type><title>Analysis of the Usefulness of the WORSEN Score for Predicting the Deterioration of Acute Ischemic Stroke</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Miyamoto, Nobukazu ; Tanaka, Ryota ; Ueno, Yuji ; Watanabe, Masao ; Kurita, Naohide ; Hira, Kenichiro ; Shimada, Yoshiaki ; Kuroki, Takuma ; Yamashiro, Kazuo ; Urabe, Takao ; Hattori, Nobutaka</creator><creatorcontrib>Miyamoto, Nobukazu ; Tanaka, Ryota ; Ueno, Yuji ; Watanabe, Masao ; Kurita, Naohide ; Hira, Kenichiro ; Shimada, Yoshiaki ; Kuroki, Takuma ; Yamashiro, Kazuo ; Urabe, Takao ; Hattori, Nobutaka</creatorcontrib><description>Early neurological worsening is associated with increased mortality and long-term functional disability. We developed the WORSEN score for predicting whether patients with stroke will deteriorate during the week after stroke onset and investigated its usefulness.
We retrospectively investigated the cases of 478 patients who were admitted to Juntendo University Hospital between April 2007 and March 2009. Neurological deterioration was defined as a worsening of 4 points or higher on the National Institute of Health Stroke Scale score within 1 week of admission. Based on a previous study, we developed the WORSEN score, which was derived from the following factors: wrong (poor) blood sugar control (W), old myocardial infarction (O), radiological findings (R), infarct size (S), elevated low-density lipoprotein cholesterol (E), and neurological findings (N). Next, we investigated the utility of this scoring system in 456 other patients who were admitted to Juntendo University Hospital and Juntendo Urayasu Hospital between October 2013 and December 2014.
First, we checked the utility of the WORSEN score for detecting worsening in cases of stroke. In the first patient group, deterioration was noted in 32.5% of the patients with scores higher than 3 points (sensitivity: .704 and specificity: .744). For checking reproductivity on using the second group, deterioration was detected in 36.1% of the patients with WORSEN scores higher than 3 points (sensitivity: .740 and specificity: .835).
Careful attention should be paid to patients with acute stroke with high WORSEN scores. The WORSEN score might become a valuable tool for detecting the neurological deterioration of ischemic stroke.</description><identifier>ISSN: 1052-3057</identifier><identifier>EISSN: 1532-8511</identifier><identifier>DOI: 10.1016/j.jstrokecerebrovasdis.2017.07.005</identifier><identifier>PMID: 28784279</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Acute ischemic stroke ; Aged ; Aged, 80 and over ; Biomarkers - blood ; Blood Glucose - metabolism ; Brain Ischemia - blood ; Brain Ischemia - diagnosis ; Brain Ischemia - physiopathology ; Cholesterol, LDL - blood ; Decision Support Techniques ; diabetes ; Disability Evaluation ; Disease Progression ; dyslipidemia ; Female ; history of myocardial infarction ; Hospitals, University ; Humans ; Japan ; Male ; Middle Aged ; Myocardial Infarction - diagnosis ; Nerve Degeneration ; neurological deterioration ; Predictive Value of Tests ; Prognosis ; Reproducibility of Results ; Retrospective Studies ; Risk Factors ; Stroke - blood ; Stroke - diagnosis ; Stroke - physiopathology ; Time Factors</subject><ispartof>Journal of stroke and cerebrovascular diseases, 2017-12, Vol.26 (12), p.2834-2839</ispartof><rights>2017 National Stroke Association</rights><rights>Copyright © 2017 National Stroke Association. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c470t-afb2563f0f422e54e3064be68a6e0ff320dd6046e439b455f5183e6cc558e8943</citedby><cites>FETCH-LOGICAL-c470t-afb2563f0f422e54e3064be68a6e0ff320dd6046e439b455f5183e6cc558e8943</cites><orcidid>0000-0003-3037-169X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1052305717303622$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28784279$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Miyamoto, Nobukazu</creatorcontrib><creatorcontrib>Tanaka, Ryota</creatorcontrib><creatorcontrib>Ueno, Yuji</creatorcontrib><creatorcontrib>Watanabe, Masao</creatorcontrib><creatorcontrib>Kurita, Naohide</creatorcontrib><creatorcontrib>Hira, Kenichiro</creatorcontrib><creatorcontrib>Shimada, Yoshiaki</creatorcontrib><creatorcontrib>Kuroki, Takuma</creatorcontrib><creatorcontrib>Yamashiro, Kazuo</creatorcontrib><creatorcontrib>Urabe, Takao</creatorcontrib><creatorcontrib>Hattori, Nobutaka</creatorcontrib><title>Analysis of the Usefulness of the WORSEN Score for Predicting the Deterioration of Acute Ischemic Stroke</title><title>Journal of stroke and cerebrovascular diseases</title><addtitle>J Stroke Cerebrovasc Dis</addtitle><description>Early neurological worsening is associated with increased mortality and long-term functional disability. We developed the WORSEN score for predicting whether patients with stroke will deteriorate during the week after stroke onset and investigated its usefulness.
We retrospectively investigated the cases of 478 patients who were admitted to Juntendo University Hospital between April 2007 and March 2009. Neurological deterioration was defined as a worsening of 4 points or higher on the National Institute of Health Stroke Scale score within 1 week of admission. Based on a previous study, we developed the WORSEN score, which was derived from the following factors: wrong (poor) blood sugar control (W), old myocardial infarction (O), radiological findings (R), infarct size (S), elevated low-density lipoprotein cholesterol (E), and neurological findings (N). Next, we investigated the utility of this scoring system in 456 other patients who were admitted to Juntendo University Hospital and Juntendo Urayasu Hospital between October 2013 and December 2014.
First, we checked the utility of the WORSEN score for detecting worsening in cases of stroke. In the first patient group, deterioration was noted in 32.5% of the patients with scores higher than 3 points (sensitivity: .704 and specificity: .744). For checking reproductivity on using the second group, deterioration was detected in 36.1% of the patients with WORSEN scores higher than 3 points (sensitivity: .740 and specificity: .835).
Careful attention should be paid to patients with acute stroke with high WORSEN scores. The WORSEN score might become a valuable tool for detecting the neurological deterioration of ischemic stroke.</description><subject>Acute ischemic stroke</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biomarkers - blood</subject><subject>Blood Glucose - metabolism</subject><subject>Brain Ischemia - blood</subject><subject>Brain Ischemia - diagnosis</subject><subject>Brain Ischemia - physiopathology</subject><subject>Cholesterol, LDL - blood</subject><subject>Decision Support Techniques</subject><subject>diabetes</subject><subject>Disability Evaluation</subject><subject>Disease Progression</subject><subject>dyslipidemia</subject><subject>Female</subject><subject>history of myocardial infarction</subject><subject>Hospitals, University</subject><subject>Humans</subject><subject>Japan</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Myocardial Infarction - diagnosis</subject><subject>Nerve Degeneration</subject><subject>neurological deterioration</subject><subject>Predictive Value of Tests</subject><subject>Prognosis</subject><subject>Reproducibility of Results</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Stroke - blood</subject><subject>Stroke - diagnosis</subject><subject>Stroke - physiopathology</subject><subject>Time Factors</subject><issn>1052-3057</issn><issn>1532-8511</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkFtP3DAQha2qFdAtf6HKY1Up2_EtyT5uubRIq4K6IB6txBmzXrIxeBwk_j3ZXcpTX5BG8mh85hz7Y-w7hykHXvxYT9eUYrhHixGbGJ5qaj1NBfByCmOB_sCOuJYirzTnH8cetMgl6PKQfSZaA3CuK33ADkVVVkqUsyO2mvd190yesuCytMLshtANXY_0Nrm9_Ls8-5MtbYiYuRCzq4itt8n3d7v7U0wYfYh18qHfLs3tkDC7ILvCjbfZcvfmL-yTqzvC49dzwm7Oz65PfueLy18XJ_NFblUJKa9dI3QhHTglBGqFEgrVYFHVBYJzUkDbFqAKVHLWKK2d5pXEwlqtK6xmSk7Yt73vQwyPA1IyG08Wu67uMQxk-EyUcjSQW-nPvdTGQBTRmYfoN3V8NhzMlrhZm_8RN1viBsYCPZp8fc0bmg22bxb_EI-CxV6A46-fPEZD1mNvR4YRbTJt8O_JewG2H6Co</recordid><startdate>201712</startdate><enddate>201712</enddate><creator>Miyamoto, Nobukazu</creator><creator>Tanaka, Ryota</creator><creator>Ueno, Yuji</creator><creator>Watanabe, Masao</creator><creator>Kurita, Naohide</creator><creator>Hira, Kenichiro</creator><creator>Shimada, Yoshiaki</creator><creator>Kuroki, Takuma</creator><creator>Yamashiro, Kazuo</creator><creator>Urabe, Takao</creator><creator>Hattori, Nobutaka</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3037-169X</orcidid></search><sort><creationdate>201712</creationdate><title>Analysis of the Usefulness of the WORSEN Score for Predicting the Deterioration of Acute Ischemic Stroke</title><author>Miyamoto, Nobukazu ; Tanaka, Ryota ; Ueno, Yuji ; Watanabe, Masao ; Kurita, Naohide ; Hira, Kenichiro ; Shimada, Yoshiaki ; Kuroki, Takuma ; Yamashiro, Kazuo ; Urabe, Takao ; Hattori, Nobutaka</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c470t-afb2563f0f422e54e3064be68a6e0ff320dd6046e439b455f5183e6cc558e8943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Acute ischemic stroke</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biomarkers - blood</topic><topic>Blood Glucose - metabolism</topic><topic>Brain Ischemia - blood</topic><topic>Brain Ischemia - diagnosis</topic><topic>Brain Ischemia - physiopathology</topic><topic>Cholesterol, LDL - blood</topic><topic>Decision Support Techniques</topic><topic>diabetes</topic><topic>Disability Evaluation</topic><topic>Disease Progression</topic><topic>dyslipidemia</topic><topic>Female</topic><topic>history of myocardial infarction</topic><topic>Hospitals, University</topic><topic>Humans</topic><topic>Japan</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Myocardial Infarction - diagnosis</topic><topic>Nerve Degeneration</topic><topic>neurological deterioration</topic><topic>Predictive Value of Tests</topic><topic>Prognosis</topic><topic>Reproducibility of Results</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Stroke - blood</topic><topic>Stroke - diagnosis</topic><topic>Stroke - physiopathology</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Miyamoto, Nobukazu</creatorcontrib><creatorcontrib>Tanaka, Ryota</creatorcontrib><creatorcontrib>Ueno, Yuji</creatorcontrib><creatorcontrib>Watanabe, Masao</creatorcontrib><creatorcontrib>Kurita, Naohide</creatorcontrib><creatorcontrib>Hira, Kenichiro</creatorcontrib><creatorcontrib>Shimada, Yoshiaki</creatorcontrib><creatorcontrib>Kuroki, Takuma</creatorcontrib><creatorcontrib>Yamashiro, Kazuo</creatorcontrib><creatorcontrib>Urabe, Takao</creatorcontrib><creatorcontrib>Hattori, Nobutaka</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of stroke and cerebrovascular diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Miyamoto, Nobukazu</au><au>Tanaka, Ryota</au><au>Ueno, Yuji</au><au>Watanabe, Masao</au><au>Kurita, Naohide</au><au>Hira, Kenichiro</au><au>Shimada, Yoshiaki</au><au>Kuroki, Takuma</au><au>Yamashiro, Kazuo</au><au>Urabe, Takao</au><au>Hattori, Nobutaka</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Analysis of the Usefulness of the WORSEN Score for Predicting the Deterioration of Acute Ischemic Stroke</atitle><jtitle>Journal of stroke and cerebrovascular diseases</jtitle><addtitle>J Stroke Cerebrovasc Dis</addtitle><date>2017-12</date><risdate>2017</risdate><volume>26</volume><issue>12</issue><spage>2834</spage><epage>2839</epage><pages>2834-2839</pages><issn>1052-3057</issn><eissn>1532-8511</eissn><abstract>Early neurological worsening is associated with increased mortality and long-term functional disability. We developed the WORSEN score for predicting whether patients with stroke will deteriorate during the week after stroke onset and investigated its usefulness.
We retrospectively investigated the cases of 478 patients who were admitted to Juntendo University Hospital between April 2007 and March 2009. Neurological deterioration was defined as a worsening of 4 points or higher on the National Institute of Health Stroke Scale score within 1 week of admission. Based on a previous study, we developed the WORSEN score, which was derived from the following factors: wrong (poor) blood sugar control (W), old myocardial infarction (O), radiological findings (R), infarct size (S), elevated low-density lipoprotein cholesterol (E), and neurological findings (N). Next, we investigated the utility of this scoring system in 456 other patients who were admitted to Juntendo University Hospital and Juntendo Urayasu Hospital between October 2013 and December 2014.
First, we checked the utility of the WORSEN score for detecting worsening in cases of stroke. In the first patient group, deterioration was noted in 32.5% of the patients with scores higher than 3 points (sensitivity: .704 and specificity: .744). For checking reproductivity on using the second group, deterioration was detected in 36.1% of the patients with WORSEN scores higher than 3 points (sensitivity: .740 and specificity: .835).
Careful attention should be paid to patients with acute stroke with high WORSEN scores. The WORSEN score might become a valuable tool for detecting the neurological deterioration of ischemic stroke.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28784279</pmid><doi>10.1016/j.jstrokecerebrovasdis.2017.07.005</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-3037-169X</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1052-3057 |
ispartof | Journal of stroke and cerebrovascular diseases, 2017-12, Vol.26 (12), p.2834-2839 |
issn | 1052-3057 1532-8511 |
language | eng |
recordid | cdi_proquest_miscellaneous_1927304634 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Acute ischemic stroke Aged Aged, 80 and over Biomarkers - blood Blood Glucose - metabolism Brain Ischemia - blood Brain Ischemia - diagnosis Brain Ischemia - physiopathology Cholesterol, LDL - blood Decision Support Techniques diabetes Disability Evaluation Disease Progression dyslipidemia Female history of myocardial infarction Hospitals, University Humans Japan Male Middle Aged Myocardial Infarction - diagnosis Nerve Degeneration neurological deterioration Predictive Value of Tests Prognosis Reproducibility of Results Retrospective Studies Risk Factors Stroke - blood Stroke - diagnosis Stroke - physiopathology Time Factors |
title | Analysis of the Usefulness of the WORSEN Score for Predicting the Deterioration of Acute Ischemic Stroke |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T03%3A23%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Analysis%20of%20the%20Usefulness%20of%20the%20WORSEN%20Score%20for%20Predicting%20the%20Deterioration%20of%20Acute%20Ischemic%20Stroke&rft.jtitle=Journal%20of%20stroke%20and%20cerebrovascular%20diseases&rft.au=Miyamoto,%20Nobukazu&rft.date=2017-12&rft.volume=26&rft.issue=12&rft.spage=2834&rft.epage=2839&rft.pages=2834-2839&rft.issn=1052-3057&rft.eissn=1532-8511&rft_id=info:doi/10.1016/j.jstrokecerebrovasdis.2017.07.005&rft_dat=%3Cproquest_cross%3E1927304634%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1927304634&rft_id=info:pmid/28784279&rft_els_id=S1052305717303622&rfr_iscdi=true |